Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Heartflow (HTFL) Research & Development (2024 - 2025)

Heartflow has reported Research & Development over the past 2 years, most recently at $18.7 million for Q4 2025.

  • Quarterly results put Research & Development at $18.7 million for Q4 2025, up 52.01% from a year ago — trailing twelve months through Dec 2025 was $63.3 million (changed N/A YoY), and the annual figure for FY2025 was $64.9 million, up 49.18%.
  • Research & Development for Q4 2025 was $18.7 million at Heartflow, up from $17.3 million in the prior quarter.
  • Over the last five years, Research & Development for HTFL hit a ceiling of $18.7 million in Q4 2025 and a floor of $9.9 million in Q2 2024.